New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 19, 2014
09:15 EDTDTV, T, DISH, CPB, ITMN, GOGO, ABT, CGENOn The Fly: Pre-market Movers
HIGHER: InterMune (ITMN), up 5.8% after reporting results from Phase 3 ASCEND study evaluating pirfenidone, shares upgraded to Outperform at Leerink... Gogo (GOGO), up 3.8% after upgraded at UBS... Abbott (ABT), up 1.4% after upgraded at Credit Suisse citing higher growth assumptions with the acquisition of CFR Pharmaceuticals... Compugen (CGEN), up 2.4% after quarterly losses not as steep as expected. LOWER: AT&T (T), down 2.7% after acquiring DirecTV (DTV) in a stock-and-cash transaction for $95 per share. DirecTV sahres are down 1.9% following the announcement, which shares of its nearest competitor DISH Network (DISH) are also down about 1.8%... Campbell Soup (CPB), down 5% after revenues miss expectations, saying its sees fiscal year profit at low end of prior view... Genworth (GNW), down 2.2% after downgraded at Morgan Stanley.
News For DTV;T;DISH;CPB;ITMN;GOGO;ABT;CGEN From The Last 14 Days
Check below for free stories on DTV;T;DISH;CPB;ITMN;GOGO;ABT;CGEN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
July 23, 2014
13:48 EDTTEarnings Preview: AT&T sentiment mixed ahead of Q2 report
Subscribe for More Information
10:27 EDTABTHouse Energy & Commerce Committee to hold a hearing
Subscribe for More Information
09:09 EDTGOGOGogo inflight Internet service selected by Japan Airlines
Subscribe for More Information
06:45 EDTABTLawmakers divided on inversion deals, NY Times says
Subscribe for More Information
July 22, 2014
07:28 EDTTAT&T volatility elevated into Q2 and outlook
Subscribe for More Information
July 21, 2014
13:25 EDTCPBCampbell Soup says dividends to increase over time in-line with earnings
Says company has been reducing overhead expenses. Says FY14 guidance is unchanged from May. Says extra week in FY14 will impact FY14 EPS by 8c per share. For FY14, the company expects incentive compensation costs will be below target levels, which will be a headwind next year. Says company will drive future growth by launching new products and enhancing distribution. Expects to resume share repurchases in FY15. Sees a modest EPS effect from share buybacks in FY15. The company forecasts continuing cost inflation in FY15. Expects FY14 input cost inflation to be between 3%-4%. Sees $400M of capital spending in FY15. Sees gross margin percentage to be stable in FY15. Comments made during the company's Investor Day conference.
11:19 EDTITMNInterMune July weekly volatility elevated
Subscribe for More Information
08:08 EDTTAT&T awarded $275M contract U.S. Department of State
Subscribe for More Information
07:41 EDTCPBCampbell Soup sees resuming strategic share repurchases next FY
07:40 EDTCPBCampbell Soup sees FY14 adjusted EPS at low end of 2%-4% range
Subscribe for More Information
07:32 EDTCPBCampbell Soup reiterates long-term target of 5%-7% adjusted EPS growth
Campbell reiterated its long-term targets of 3 to 4 percent organic sales growth, 4 to 6 percent adjusted EBIT growth and 5 to 7 percent adjusted EPS growth. While Campbell expects an improvement in its organic sales performance for the coming year, the company’s fiscal 2015 performance is expected to be below these long-term targets. The company indicated that it may need to continue reshaping its portfolio to achieve these long-term goals.
07:32 EDTCPBCampbell Soup sees FY15 gross margin percentage comparable to FY14
Subscribe for More Information
07:31 EDTCPBCampbell Soup still sees FY14 adjusted EPS $2.53-$2.58, consensus $2.54
For the year, Campbell expects growth of approximately 3% in net sales from continuing operations and growth in adjusted EBIT at the low end of the 4%-6% range. Adjusted EPS is expected to grow at the low end of the 2%-4% range, or $2.53 to $2.58 per share.
07:30 EDTCPBCampbell Soup reaffirms FY14 guidance
Subscribe for More Information
07:22 EDTCPBCampbell Soup to hold an investor day
Subscribe for More Information
July 18, 2014
16:47 EDTABTMarket ends week higher as earnings, M&A offset geopolitical tensions
Subscribe for More Information
12:51 EDTABTKey GOP senator signals readiness for inversion deal, The Hill says
Subscribe for More Information
July 17, 2014
12:42 EDTITMNInterMune receives FDA Breakthrough Therapy Designation for pirfenidone
InterMune announced that pirfenidone has been granted Breakthrough Therapy Designation from the U.S. FDA. This designation is reserved for drugs that are intended to treat a serious or life threatening disease or condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints. Pirfenidone is an investigational treatment for adult patients with idiopathic pulmonary fibrosis.
09:06 EDTTAT&T and town of Carrboro sign agreement for 1 Gigabit network
Subscribe for More Information
07:06 EDTABTAbbott price target raised to $47 from $42 at Stifel
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use